BANGERLABS
Fulfilled in the USA Batch Produced & Tested Fast & Discreet Shipping ≥99% Purity Guaranteed COA Every Batch Independently Tested 24/7 Support Fulfilled in the USA Batch Produced & Tested Fast & Discreet Shipping ≥99% Purity Guaranteed COA Every Batch Independently Tested 24/7 Support
Banger.
Login / Register

IGF-1 LR3 vs HGH 191AA: Research Comparison (2026)

By the Banger Labs Research Team · Updated June 2026

IGF-1 LR3 vs HGH 191AA research peptides

Short answer: IGF-1 LR3 is a synthetic, recombinant analog of insulin-like growth factor-1 used strictly as a research reference compound and cell-culture reagent. This material is for laboratory research use only and is not a drug, supplement, or therapy; no human or clinical use is implied. HGH 191AA (somatropin) is a recombinant 191-amino-acid polypeptide with a sequence identical to the principal endogenous human growth hormone, supplied strictly as a research-use-only reference material for in vitro and preclinical laboratory study. This material is not for human or veterinary use, diagnostic use, or any therapeutic application. They are compared below by class, mechanism, and research context.

IGF-1 LR3 vs HGH 191AA at a glance

Attribute IGF-1 LR3 HGH 191AA
Class Synthetic recombinant IGF-1 analog (83-residue insulin-like growth factor-1 variant) Recombinant 191-amino-acid polypeptide hormone (recombinant human growth hormone)
Primary research area Studied as a reference IGF-1R agonist in receptor-signaling and binding-characterization research Studied as a reference ligand in growth-hormone receptor (GHR) binding and dimerization research models
Purity standard ≥ 99% HPLC ≥ 99% HPLC
Use Research use only Research use only
IGF-1 LR3 — research illustration

What is IGF-1 LR3?

IGF-1 LR3 (“Long R3 IGF-1”) is an engineered analog of native human IGF-1 that contains 83 amino acids versus the native 70. It carries an arginine substituted for glutamic acid at position 3 (“R3”) plus a 13-residue N-terminal extension, and is produced recombinantly. It is described in the research literature and used as a laboratory reference compound and a cell-culture supplement.

HGH 191AA — research illustration

What is HGH 191AA?

Somatropin is a recombinant form of the dominant 191-amino-acid isoform of human growth hormone (approximately 22 kDa), produced by recombinant expression in bacterial or mammalian cell systems. Structurally it adopts a characteristic four-helix-bundle topology stabilized by two intramolecular disulfide bonds, and it belongs to the somatotropin/cytokine-family polypeptide hormone class. In a research setting it is handled as a reference polypeptide for studying growth-hormone biology.

IGF-1 LR3 research setting

How they differ

In preclinical and in-vitro studies, IGF-1 LR3 acts as an agonist at the type-1 IGF receptor (IGF-1R), a receptor tyrosine kinase, with downstream signaling reported through the PI3K/Akt and MAPK/ERK pathways. Its defining feature in the literature is markedly reduced binding affinity for the IGF-binding proteins (IGFBPs) relative to native IGF-1, which has been characterized in competitive-binding and animal-model studies. This altered IGFBP interaction is the basis for the differing tissue and gene-expression responses observed between IGF-1 LR3 and native IGF-1 in research models. By contrast, In published mechanistic studies, growth hormone binds the growth hormone receptor (GHR), a member of the class I cytokine receptor superfamily, with one hormone molecule engaging two receptor subunits and inducing a conformational change in pre-formed receptor dimers. This activates the receptor-associated JAK2 tyrosine kinase, which phosphorylates the receptor and STAT proteins (notably STAT5B), driving transcription of target genes. A central downstream node reported in the literature is stimulation of insulin-like growth factor-1 (IGF-1) production, predominantly in the liver; the MAPK and PI3K pathways are also reported as activated.

HGH 191AA research setting

These describe laboratory/preclinical research only. No therapeutic, medical, or efficacy claims are made.

Frequently asked questions

Are IGF-1 LR3 and HGH 191AA the same?

No — see the comparison table above; they differ in class and the research contexts in which they are studied.

Are these research use only?

Yes. Both are supplied strictly for laboratory research — not for human or veterinary use.

References

  1. IGF-1 LR3 — Wikipedia (overview with cited primary references)
  2. Insulin-like growth factor I (IGF-I) and long R(3)IGF-I differently affect development and mRNA abundance for IGF-binding proteins and type I IGF receptors in in vitro produced bovine embryos — Endocrinology, 2001;142(3):1309-16 (PMID 11181549)
  3. Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig — Journal of Endocrinology, 1995;146(2):247-53 (PMID 7561636)
  4. Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection — Journal of Endocrinology, 1996;150(1):77-84 (PMID 8708565)
  5. The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects — Frontiers in Endocrinology, 2018 (PMC)
  6. Growth hormone signaling pathways — Growth Hormone & IGF Research, 2015 (PMC)
  7. Human Growth Disorders Associated with Impaired GH action: Defects in STAT5B and JAK2 — Molecular and Cellular Endocrinology, 2020 (PMC)
  8. Growth hormone — Wikipedia (overview/structure reference)

Shop these research peptides

Shop IGF-1 LR3 →Shop HGH 191AA →

By the Banger Labs Research Team. For research use only. Not for human or veterinary use. Educational information, not medical advice.